Assessment of the Risk of Zoonotic Infections in Prisons in French Guiana

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier de Cayenne

About this trial

The prison system in French Guiana is characterized by severe overcrowding, high levels of promiscuity, poor sanitary conditions, and the documented presence of potential reservoirs or vectors of zoonotic diseases, particularly swallows and rodents.

In French Guiana, several zoonotic diseases have a high incidence or are of particular public health significance, including Q fever, leptospirosis, Chagas disease, histoplasmosis, and toxoplasmosis. Despite this context, the risk of zoonotic diseases in prisons remains poorly documented, even though endemic and epidemic circulation of Q fever has already been described at the French Guiana correctional facility. This study aims to document this risk in a systematic and prospective manner.

The main objective is to assess the prevalence of zoonotic infections (Q fever, leptospirosis, Chagas disease, histoplasmosis, and toxoplasmosis) among inmates at the French Guiana Correctional Facility in 2026-2027.

The other objectives are :

* To measure the seroprevalence of zoonotic infections among new arrivals at the French Guiana correctional facility; * To identify individual risk factors, both within and outside the prison, for acquiring zoonotic infections; * To analyze the results in relation to bioclimatic data (wind direction, humidity, precipitation, temperature) The expected benefits will aim to objectively assess the risk of zoonotic diseases within the French Guiana correctional facility, to improve understanding of zoonoses in prison settings, to guide the implementation of appropriate prevention and screening measures, and to contribute to improving health conditions in detention.

It should also strengthen cooperation between health and justice officials as part of an integrated approach to the prevention and management of infectious diseases.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adult aged 18 or older

Incarcerated and housed at the French Guiana Correctional Facility for 15 days or less.

Disqualifiers

Refusing to participate in the study

Pregnant women

Had already participated in the study

Trial population

Adults above 18 years old, incarcerated and housed at the French Guiana Correctional Facility for 15 days or less, from september 2026 to september 2028

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

450 Participants
are grouped into 1 trial group
Group A: Cohort participants

Trial outcomes

Primary outcomes

1

Incidence rate of zoonotic infections of interest (Q fever, leptospirosis, Chagas disease, histoplasmosis, toxoplasmosis) among participants who were seronegative for the infection in question at enrollment

Number of new infections documented during follow-up divided by the person-time actually observed in detention at the correctional facility, from enrollment until the occurrence of the event, the last available visit, release, transfer, withdrawal of consent, or the end of follow-up at 12 months.

Time frame
Baseline, Month 4, Month 8, Month 12

Secondary outcomes

1

Seroprevalence of Q fever at baseline

Proportion of participants with positive Q fever serology at enrollment

Time frame
At Baseline
2

Seroprevalence of leptospirosis at baseline

Proportion of participants with positive Q leptospirosis serology at enrollment

Time frame
At Baseline
3

Seroprevalence of Chagas disease at baseline

Proportion of participants with positive Chagas disease serology at enrollment

Time frame
At Baseline
4

Seroprevalence of toxoplasmosis at baseline

Proportion of participants with positive toxoplasmosis serology at enrollment

Time frame
At Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Centre Hospitalier de Cayenne

Lead sponsor

European Founds for regional Developement (FEDER)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: